Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bevan

Showing results (171-180 of 238) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trialPhilippe J Caron, John S Bevan, Stephan Petersenn, et al.
Clinical Endocrinology|March 1, 1989
Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenomaJ S Bevan, S L Asa, M L Rossi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2013
A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonistsW M Drake, C E Stiles, T A Howlett, et al.
Thrombosis Research|October 14, 2009
Platelet activation and endogenous thrombin potential in pre-eclampsiaM G Macey, S Bevan, S Alam, et al.
Clinical Endocrinology|July 9, 1999
Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretionS J Hunter, J A Shaw, K O Lee, et al.
The Biochemical Journal|July 1, 1992
Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitroG Dimitriadis, M Parry-Billings, S Bevan, et al.
Clinical Endocrinology|January 1, 1992
Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function testsJ Webster, M D Page, J S Bevan, et al.
Clinical Endocrinology|August 1, 1996
Laparoscopic trans-peritoneal adrenalectomy: a preliminary report of 14 adrenalectomiesD Walmsley, R McIntyre, H A Sawers, et al.
Clinical Endocrinology|July 1, 1989
Studies of two thyrotrophin-secreting pituitary adenomas: evidence for dopamine receptor deficiencyJ S Bevan, C W Burke, M M Esiri, et al.
Lancet (London, England)|June 9, 1990
Vasopressin antagonist in early postoperative diabetes insipidusJ R Seckl, D B Dunger, J S Bevan, et al.
Pageof 24

Showing results (171-180 of 238) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trialPhilippe J Caron, John S Bevan, Stephan Petersenn, et al.
Clinical Endocrinology|March 1, 1989
Intrasellar gangliocytoma containing gastrin and growth hormone-releasing hormone associated with a growth hormone-secreting pituitary adenomaJ S Bevan, S L Asa, M L Rossi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2013
A cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonistsW M Drake, C E Stiles, T A Howlett, et al.
Thrombosis Research|October 14, 2009
Platelet activation and endogenous thrombin potential in pre-eclampsiaM G Macey, S Bevan, S Alam, et al.
Clinical Endocrinology|July 9, 1999
Comparison of monthly intramuscular injections of Sandostatin LAR with multiple subcutaneous injections of octreotide in the treatment of acromegaly; effects on growth hormone and other markers of growth hormone secretionS J Hunter, J A Shaw, K O Lee, et al.
The Biochemical Journal|July 1, 1992
Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitroG Dimitriadis, M Parry-Billings, S Bevan, et al.
Clinical Endocrinology|January 1, 1992
Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function testsJ Webster, M D Page, J S Bevan, et al.
Clinical Endocrinology|August 1, 1996
Laparoscopic trans-peritoneal adrenalectomy: a preliminary report of 14 adrenalectomiesD Walmsley, R McIntyre, H A Sawers, et al.
Clinical Endocrinology|July 1, 1989
Studies of two thyrotrophin-secreting pituitary adenomas: evidence for dopamine receptor deficiencyJ S Bevan, C W Burke, M M Esiri, et al.
Lancet (London, England)|June 9, 1990
Vasopressin antagonist in early postoperative diabetes insipidusJ R Seckl, D B Dunger, J S Bevan, et al.
Pageof 24